• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用作酒精厌恶疗法的药物所致肝炎。

Hepatitis induced by drugs used as alcohol aversion therapy.

作者信息

Vázquez J J, Diaz de Otazu R, Guillen F J, Zozaya J, Pardo F J

出版信息

Diagn Histopathol. 1983 Jan-Mar;6(1):29-37.

PMID:6307616
Abstract

We report here on the hepatic lesions produced in 17 alcoholic patients who had received Cyanamide or Disulfiram as aversion therapy. The characteristic lesion consists of cytoplasmic inclusions, similar to Lafora bodies. They are found predominantly in periportal hepatocytes, including those lining the cholangioles. They appear to be persistent but are lost after death of the inclusion-bearing liver-cell when both the inclusion body and the dead hepatocyte are removed by macrophages. As well as the inclusion bodies, portal or periportal inflammation and necrosis of isolated liver-cells are seen. The inflammatory infiltrate is usually denser in the periportal areas and is associated with liver-cell destruction. The inflammation is usually followed by portal fibrosis which can be severe if treatment is prolonged. In one case, in which two biopsies were performed, cirrhosis developed while that patient was on Cyanamide.

摘要

我们在此报告17例接受氨甲酰或双硫仑作为厌恶疗法的酒精性患者所产生的肝脏病变。特征性病变包括细胞质内包涵体,类似于拉福拉小体。它们主要见于汇管区周围的肝细胞,包括胆小管内衬的肝细胞。这些包涵体似乎持续存在,但在含包涵体的肝细胞死亡后会消失,此时包涵体和死亡的肝细胞会被巨噬细胞清除。除了包涵体外,还可见门管区或汇管区周围炎症以及单个肝细胞坏死。炎症浸润通常在汇管区周围更为密集,并与肝细胞破坏有关。炎症通常随后会出现门管区纤维化,如果治疗时间延长,纤维化可能会很严重。在1例进行了两次活检的病例中,该患者在服用氨甲酰期间发展为肝硬化。

相似文献

1
Hepatitis induced by drugs used as alcohol aversion therapy.用作酒精厌恶疗法的药物所致肝炎。
Diagn Histopathol. 1983 Jan-Mar;6(1):29-37.
2
Cyanamide-induced liver injury. A predictable lesion.氰胺引起的肝损伤。一种可预测的病变。
Liver. 1983 Aug;3(4):225-30. doi: 10.1111/j.1600-0676.1983.tb00872.x.
3
Hepatic disease associated with ground-glass inclusions in hepatocytes after cyanamide therapy.
Arch Pathol Lab Med. 1986 Oct;110(10):906-10.
4
Cyanamide hepatotoxicity. Incidence and clinico-pathological features.氰胺肝毒性。发病率及临床病理特征。
Liver. 1987 Aug;7(4):216-22.
5
Comparison of cyanamide and disulfiram in effects on liver function.氨基氰和双硫仑对肝功能影响的比较。
Alcohol Clin Exp Res. 2000 Apr;24(4 Suppl):97S-99S.
6
Structural hepatic changes associated with cyanamide treatment: cholangiolar proliferation, fibrosis and cirrhosis.与氰胺治疗相关的肝脏结构变化:胆小管增生、纤维化和肝硬化。
Liver. 1984 Feb;4(1):15-21. doi: 10.1111/j.1600-0676.1984.tb00902.x.
7
Cyanamide-induced liver dysfunction after abstinence in alcoholics: a long-term follow-up study on four cases.
Alcohol Clin Exp Res. 2000 Apr;24(4 Suppl):100S-105S.
8
Cyanamide-induced liver injury in alcoholics.酒精性患者中氨基氰诱发的肝损伤。
Lancet. 1980 Feb 16;1(8164):361-2. doi: 10.1016/s0140-6736(80)90903-4.
9
Ground glass inclusions in liver cells in an alcoholic treated with cyanamide (Dipsan).在用氨甲脒(迪普散)治疗的酒精性患者的肝细胞中出现磨玻璃样包涵体。
Liver. 1981 Mar;1(1):67-73. doi: 10.1111/j.1600-0676.1981.tb00024.x.
10
Cyanamide-associated alcoholic liver disease: a sequential histological evaluation.氰胺相关酒精性肝病:一项连续组织学评估
Alcohol Clin Exp Res. 1995 Oct;19(5):1307-11. doi: 10.1111/j.1530-0277.1995.tb01616.x.